Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Burlington, VT
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Falls Church, VA
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Falls Church, VA
Click here to add this to my saved trials
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Norfolk, VA
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Seattle, WA
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Madison, WI
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation
A Randomized, Open-label Study of Various Dosing Regimens of CellCept Combined With Various Dosing Regimens of Cyclosporine or Tacrolimus on Treatment Failure in Kidney Transplantation Patients
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
A Phase 1 Study to Evaluate the Pharmacokinetics of ITCA 650 in Subjects With Mild and Moderate Renal Impairment Compared to the Pharmacokinetics of Subjects With Normal Renal Function
Status: Enrolling
Updated:  6/2/2016
Intarcia Therapeutics Inc.
mi
from
Boston, MA
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
A Phase 1 Study to Evaluate the Pharmacokinetics of ITCA 650 in Subjects With Mild and Moderate Renal Impairment Compared to the Pharmacokinetics of Subjects With Normal Renal Function
Status: Enrolling
Updated: 6/2/2016
Intarcia Therapeutics Inc.
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
A Phase 1 Study to Evaluate the Pharmacokinetics of ITCA 650 in Subjects With Mild and Moderate Renal Impairment Compared to the Pharmacokinetics of Subjects With Normal Renal Function
Status: Enrolling
Updated:  6/2/2016
Study Site
mi
from
Kiel,
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
A Phase 1 Study to Evaluate the Pharmacokinetics of ITCA 650 in Subjects With Mild and Moderate Renal Impairment Compared to the Pharmacokinetics of Subjects With Normal Renal Function
Status: Enrolling
Updated: 6/2/2016
Study Site
mi
from
Kiel,
Click here to add this to my saved trials
Inferior Vena Cava (IVC) Size in Acute Renal Failure
Does the Inferior Vena Cava Size Assessment Help in the Management of Acute Kidney Injury in Critically Ill Patients?
Status: Enrolling
Updated:  6/8/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Inferior Vena Cava (IVC) Size in Acute Renal Failure
Does the Inferior Vena Cava Size Assessment Help in the Management of Acute Kidney Injury in Critically Ill Patients?
Status: Enrolling
Updated: 6/8/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Patients With Acute Renal Failure on CVVH
The Role of Hemodynamics, Cytokine Response, and Modulators of Apoptosis on Urine Output in Patients With Acute Renal Failure on CVVH
Status: Enrolling
Updated:  6/13/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Study of Patients With Acute Renal Failure on CVVH
The Role of Hemodynamics, Cytokine Response, and Modulators of Apoptosis on Urine Output in Patients With Acute Renal Failure on CVVH
Status: Enrolling
Updated: 6/13/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Clinical Research Center, Inc.
mi
from
Birmingham, AL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Clinical Research Center, Inc.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Clinical Research Consultants, Inc.
mi
from
Hoover, AL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Clinical Research Consultants, Inc.
mi
from
Hoover, AL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
University of South Alabama
mi
from
Mobile, AL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
University of South Alabama
mi
from
Mobile, AL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Montgomery Kidney Specialists
mi
from
Montgomery, AL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Montgomery Kidney Specialists
mi
from
Montgomery, AL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
California Kidney Specialist
mi
from
Covina, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
California Kidney Specialist
mi
from
Covina, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Atlantic Avenue Medical Clinic
mi
from
Cudahy, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Atlantic Avenue Medical Clinic
mi
from
Cudahy, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
East Bay-South Hayward Dialysis Center
mi
from
Hayward, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
East Bay-South Hayward Dialysis Center
mi
from
Hayward, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Renal Research Center
mi
from
Los Alamitos, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Renal Research Center
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
USC Kidney Center
mi
from
Los Angeles, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
USC Kidney Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Beverly Nephrology
mi
from
Los Angeles, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Beverly Nephrology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Tower Nephrology Medical Group
mi
from
Los Angeles, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Tower Nephrology Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
USC DaVita Dialysis Center
mi
from
Los Angeles, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
USC DaVita Dialysis Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Renal Medical Associates
mi
from
Lynwood, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Renal Medical Associates
mi
from
Lynwood, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Valley Renal Medical Group
mi
from
Northridge, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Valley Renal Medical Group
mi
from
Northridge, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Desert Nephrolgy Medical Group
mi
from
Palm Springs, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Desert Nephrolgy Medical Group
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Palo Alto Nephrology
mi
from
Palo Alto, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Palo Alto Nephrology
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Pasadena Nephrology
mi
from
Pasadena, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Pasadena Nephrology
mi
from
Pasadena, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Capital Nephrology
mi
from
Sacramento, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Capital Nephrology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Citrus Valley Dialysis Center
mi
from
San Bernardino, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Citrus Valley Dialysis Center
mi
from
San Bernardino, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
California Kidney Specialist
mi
from
San Dimas, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
California Kidney Specialist
mi
from
San Dimas, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
San Francisco Dialysis Center # 3830
mi
from
San Francisco, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
San Francisco Dialysis Center # 3830
mi
from
San Francisco, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Habib A. Tobbagi, MD
mi
from
San Jose, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Habib A. Tobbagi, MD
mi
from
San Jose, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Selma DaVita Dialysis
mi
from
Selma, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Selma DaVita Dialysis
mi
from
Selma, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Pear Tree Dialysis
mi
from
Ukiah, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Pear Tree Dialysis
mi
from
Ukiah, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
High Desert Nephrology
mi
from
Victorville, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
High Desert Nephrology
mi
from
Victorville, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Renal Medical Group
mi
from
Visalia, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Renal Medical Group
mi
from
Visalia, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
North Valley Nephrology
mi
from
Yuba City, CA
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
North Valley Nephrology
mi
from
Yuba City, CA
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Hartford North
mi
from
Hartford, CT
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Hartford North
mi
from
Hartford, CT
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Metabolism Associates
mi
from
New Haven, CT
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Metabolism Associates
mi
from
New Haven, CT
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Torrington Dialysis
mi
from
Torrington, CT
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Torrington Dialysis
mi
from
Torrington, CT
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Davita-Brentwood
mi
from
Washington,
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Davita-Brentwood
mi
from
Washington,
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Lee Street Dialysis
mi
from
Washington,
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Lee Street Dialysis
mi
from
Washington,
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Union Plaza Dialysis Center
mi
from
Washington,
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Union Plaza Dialysis Center
mi
from
Washington,
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
PAB Clinical Resesarch
mi
from
Brandon, FL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
PAB Clinical Resesarch
mi
from
Brandon, FL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
South Florida Nephrology Group
mi
from
Coral Springs, FL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
South Florida Nephrology Group
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Nephrology Consultants, PA
mi
from
Daytona Beach, FL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Nephrology Consultants, PA
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
DaVita Fort Myers
mi
from
Fort Myers, FL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
DaVita Fort Myers
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Nephrology Associates
mi
from
Fort Pierce, FL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Nephrology Associates
mi
from
Fort Pierce, FL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Outcomes Research International Inc.
mi
from
Hudson, FL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Outcomes Research International Inc.
mi
from
Hudson, FL
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated:  6/15/2016
Central Florida Kidney Care, PA
mi
from
Lakeland, FL
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Central Florida Kidney Care, PA
mi
from
Lakeland, FL
Click here to add this to my saved trials